News
Zacks.com on MSN23h
BMY vs GSK: Which Biopharma Bigwig Has Better Prospects for Now?
Bristol Myers leans on new launches to offset legacy drug declines, while GSK's diverse portfolio and strong HIV lineup keep growth on track.
Legit.ng on MSN23h
FG Reduces Dialysis Cost in Nigeria from N50k to N12k, Releases List of Federal Hospitals
The Nigerian government has reduced the cost of dialysis for kidney patients from N50,000 to N12,000 per session at federal ...
The Business Research Company The Business Research Company's Pediatric Asthma Treatment Global Market Report 2025 – Market Size, Trends, A ...
The global Epiglottitis Treatment Market is projected to grow from USD 11.5 billion in 2025 to USD 18.4 billion by 2035, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback